Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RAB9A | P51151 | 3/20 | 0.40 |
| ▸ | NPC1 | O15118 | 2/20 | 0.40 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.40 |
| ▸ | L3MBTL1 | Q9Y468 | 3/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.35 |
| ▸ | SIRT5 | Q9NXA8 | 1/20 | 0.35 |
| ▸ | POLB | P06746 | 2/20 | 0.33 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.33 |
| ▸ | HTT | P42858 | 1/20 | 0.32 |
| ▸ | MAPT | P10636 | 1/20 | 0.32 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.32 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.32 |
| ▸ | ADRB1 | P08588 | 1/20 | 0.32 |
| ▸ | ADRB3 | P13945 | 1/20 | 0.32 |
| ▸ | GLS | O94925 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7037676 | 0.89 | RAB9A (0.42) | RAB9ANPC1TDP1L3MBTL1KMT2A | |
| SCHEMBL6291029 | 0.86 | RAB9A (0.43) | RAB9ANPC1TDP1L3MBTL1KMT2A | |
| SCHEMBL6285275 | 0.85 | RAB9A (0.38) | RAB9ANPC1TDP1L3MBTL1KMT2A | |
| Hydrochloric Acid SCHEMBL6287062 | 0.85 | RAB9A (0.39) | RAB9ANPC1TDP1L3MBTL1KMT2A | |
| Hydrochloric Acid SCHEMBL6285424 | 0.85 | RAB9A (0.39) | RAB9ANPC1TDP1L3MBTL1KMT2A | |
| Hydrochloric Acid SCHEMBL6287055 | 0.83 | RAB9A (0.36) | RAB9ANPC1TDP1L3MBTL1KMT2A | |
| Hydrochloric Acid SCHEMBL6287756 | 0.83 | RAB9A (0.36) | RAB9ANPC1TDP1L3MBTL1KMT2A | |
| SCHEMBL6290991 | 0.82 | RAB9A (0.41) | RAB9ANPC1TDP1L3MBTL1KMT2A | |
| SCHEMBL6290320 | 0.78 | CA1 (0.39) | RAB9ANPC1TDP1L3MBTL1SIRT5 | |
| SCHEMBL6287076 | 0.78 | CA1 (0.39) | RAB9ANPC1TDP1L3MBTL1SIRT5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6887890-B2 | Compounds exhibiting thrombopoietin-like activities | CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) | 2005-05-03 | — | — | US | disclosed |
| US-20030162724-A1 | Compounds exhibiting thrombopoietin-like activities | CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) | 2003-08-28 | — | — | US | disclosed |
| EP-1291341-A1 | COMPOUNDS EXHIBITING THROMBOPOIETIN-LIKE ACTIVITIES | CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) | 2003-03-12 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030162724-A1 | Compounds exhibiting thrombopoietin-like activities | MPL, THPO, TEK | RAB9A 4327/4885NPC1 3910/4885TDP1 4329/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.